ANG1005 Drug Record

  • ANG1005 chembl:CHEMBL1089636 Antineoplastic

    Alternate Names:

    ANG1005
    PACLITAXEL TREVATIDE
    ANG-1005

    Drug Info:

    FDA Approval not approved
    Drug Class fusion protein
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • ANG1005   BCL2

    Interaction Score: 0.72

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ANG1005
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ANG1005   TUBB1

    Interaction Score: 0.59

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ANG1005
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: ANG1005

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class fusion protein
    FDA Approval not approved

    Publications:

  • ChemblDrugs: chembl:CHEMBL1089636

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: